Espero Pharmaceuticals Announces Promotion of Nitrolingual® Pumpspray (nitroglycerin lingual spray)

JACKSONVILLE, Fla.–(BUSINESS WIRE)–Espero Pharmaceuticals, Inc., (http://www.esperopharma.com) a privately held specialty pharmaceutical company, today assumed the U.S. promotional responsibility for Nitrolingual® Pumpspray, in an exclusive licensing agreement with G. Pohl-Boskamp GmbH & Co. KG (“Pohl-Boskamp”), a fully-integrated German pharmaceutical company. Jacksonville Pharmaceuticals, a wholly owned subsidiary of Espero Pharmaceuticals, has also assumed distribution and supply responsibility […]

Read more